$Zai Lab Ltd(ZLAB)$ holds nearly $900 million in cash reserves, with FcRn making strong moves in the Chinese market. Looking ahead, CNS molecules, autoimmune bispecifics, and ADCs are all worth anticipating!
Zai Lab’s exceptional execution has successfully driven drug development, approval, and commercialization across multiple disease areas, delivering impressive sales performance. I’m staying strong in this ride!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
